Phoenix Financial’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
Phoenix Financial's CLBT Position: Q3 2026 in Review
Phoenix Financial reduced its Cellebrite (CLBT) stake by 17% in Q3 2026, selling an estimated $14.2M and leaving 5,111,006 shares worth $57.6M. The position accounts for 0.39% of the portfolio, ranked #61.
Phoenix Financial first reported a position in CLBT in Q4 2021 and has held it in 20 quarters since. The position peaked at $90.2M in Q2 2026. 67 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.
- Phoenix Financial held 5,111,006 shares of Cellebrite worth $57.6M as of Q3 2026.
- Phoenix Financial sold 1,070,263 Cellebrite shares in Q3 2026, an estimated $14.2M.
- Cellebrite made up 0.39% of Phoenix Financial's portfolio in Q3 2026, its #61 holding.
- Phoenix Financial first reported a position in Cellebrite in Q4 2021 and has held it in 20 quarters since.
- Phoenix Financial's Cellebrite position peaked at $90.2M in Q2 2026.
- 67 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.
Based on Phoenix Financial's 13F filing for Q3 2026, filed 9 Nov 2026.